These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27917125)

  • 1. Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail.
    Berger B; Donzelli M; Maseneni S; Boess F; Roth A; Krähenbühl S; Haschke M
    Front Pharmacol; 2016; 7():443. PubMed ID: 27917125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.
    Derungs A; Donzelli M; Berger B; Noppen C; Krähenbühl S; Haschke M
    Clin Pharmacokinet; 2016 Jan; 55(1):79-91. PubMed ID: 26123704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of deglucuronidation on the results of the Basel phenotyping cocktail.
    Bachmann F; Duthaler U; Krähenbühl S
    Br J Clin Pharmacol; 2021 Dec; 87(12):4608-4618. PubMed ID: 33890704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protein binding on the pharmacokinetics of the six substrates in the Basel phenotyping cocktail in healthy subjects and patients with liver cirrhosis.
    Duthaler U; Chapuisat F; Hanimann R; Krähenbühl S
    Eur J Pharm Sci; 2024 Nov; 202():106885. PubMed ID: 39182854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Cirrhosis Affects the Pharmacokinetics of the Six Substrates of the Basel Phenotyping Cocktail Differently.
    Duthaler U; Bachmann F; Suenderhauf C; Grandinetti T; Pfefferkorn F; Haschke M; Hruz P; Bouitbir J; Krähenbühl S
    Clin Pharmacokinet; 2022 Jul; 61(7):1039-1055. PubMed ID: 35570253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
    Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
    J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug.
    Berger B; Bachmann F; Duthaler U; Krähenbühl S; Haschke M
    Front Pharmacol; 2018; 9():774. PubMed ID: 30087611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spots.
    Donzelli M; Derungs A; Serratore MG; Noppen C; Nezic L; Krähenbühl S; Haschke M
    Clin Pharmacokinet; 2014 Mar; 53(3):271-282. PubMed ID: 24218006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction.
    Järvinen E; Hammer HS; Pötz O; Ingelman-Sundberg M; Stage TB
    Clin Pharmacol Ther; 2023 Jun; 113(6):1284-1294. PubMed ID: 36906857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2.
    Bachmann F; Duthaler U; Meyer Zu Schwabedissen HE; Puchkov M; Huwyler J; Haschke M; Krähenbühl S
    Clin Pharmacol Ther; 2021 Jun; 109(6):1505-1516. PubMed ID: 33336382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
    Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
    Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
    Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
    Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-throughput assay using liquid chromatography-tandem mass spectrometry for simultaneous in vivo phenotyping of 5 major cytochrome p450 enzymes in patients.
    Ghassabian S; Chetty M; Tattam BN; Chem MC; Glen J; Rahme J; Stankovic Z; Ramzan I; Murray M; McLachlan AJ
    Ther Drug Monit; 2009 Apr; 31(2):239-46. PubMed ID: 19307938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
    Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
    Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
    J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human Hepatocytes.
    Iversen DB; Dunvald AD; Jespersen DM; Nielsen F; Brøsen K; Damkier P; Hammer HS; Pötz O; Järvinen E; Stage TB
    Clin Pharmacol Ther; 2023 Aug; 114(2):434-445. PubMed ID: 37235733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An improved cytochrome P450 phenotyping cocktail with a simplified and highly sensitive UHPLC-MS/MS assay in human plasma.
    Eagles SK; Wang X; Gross AS; McLachlan AJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():122013. PubMed ID: 32050158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.